BridgeMD
New treatment option for IgA Nephropathy
Official title Study of BHV-1400 in IgA Nephropathy
ClinicalTrials.gov ID: NCT07054684
What this study is testing
What is BHV-1400?
BHV-1400 is an investigational medicine, given as an injection under the skin, being studied as a potential treatment for iga nephropathy.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study is to determine if BHV-1400 is a safe and tolerable treatment in participants with IgA Nephropathy (IgAN).
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- 1\. Participants must have biopsy-confirmed IgA Nephropathy
You likely can't join if
- Any secondary IgAN
- Any cause of chronic kidney disease not diagnosed as IgAN or due to non-IgAN cause
The study team makes the final eligibility decision.
Where it's taking place
- Farmington, Connecticut, United States
- Miami Lakes, Florida, United States
- Orlando, Florida, United States
- Pembroke Pines, Florida, United States
- Lawrenceville, Georgia, United States
- Hinsdale, Illinois, United States
- Indianapolis, Indiana, United States
- Shelby, Michigan, United States
- Chesterfield, Missouri, United States
- Dakota Dunes, South Dakota, United States
- Houston, Texas, United States
- Salt Lake City, Utah, United States
- Leicester, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Farmington, Connecticut, United States; Miami Lakes, Florida, United States; Orlando, Florida, United States; Pembroke Pines, Florida, United States; Lawrenceville, Georgia, United States; Hinsdale, Illinois, United States and 7 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.